294 related articles for article (PubMed ID: 28642177)
1. Protective Functions of PJ34, a Poly(ADP-ribose) Polymerase Inhibitor, Are Related to Down-Regulation of Calpain and Nuclear Factor-κB in a Mouse Model of Traumatic Brain Injury.
Tao X; Chen X; Hou Z; Hao S; Liu B
World Neurosurg; 2017 Nov; 107():888-899. PubMed ID: 28642177
[TBL] [Abstract][Full Text] [Related]
2. Protective actions of PJ34, a poly(ADP-ribose)polymerase inhibitor, on the blood-brain barrier after traumatic brain injury in mice.
Tao X; Chen X; Hao S; Hou Z; Lu T; Sun M; Liu B
Neuroscience; 2015 Apr; 291():26-36. PubMed ID: 25668593
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of PARP inhibitor, PJ34, is related to down-regulation of calpain and NF-κB in a mouse model of TBI.
Tao X; Chen X; Mao X; Hou Z; Hao S; Tian R; Zhu Z; Sun M; Liu B
Brain Inj; 2016 Apr; ():1-11. PubMed ID: 27119554
[TBL] [Abstract][Full Text] [Related]
4. Protective Effects of Calpain Inhibition on Neurovascular Unit Injury through Downregulating Nuclear Factor-κB-related Inflammation during Traumatic Brain Injury in Mice.
Tao XG; Shi JH; Hao SY; Chen XT; Liu BY
Chin Med J (Engl); 2017 Jan; 130(2):187-198. PubMed ID: 28091411
[TBL] [Abstract][Full Text] [Related]
5. PARP inhibition attenuates early brain injury through NF-κB/MMP-9 pathway in a rat model of subarachnoid hemorrhage.
Chen T; Wang W; Li JR; Xu HZ; Peng YC; Fan LF; Yan F; Gu C; Wang L; Chen G
Brain Res; 2016 Aug; 1644():32-8. PubMed ID: 27157545
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of proliferation and invasiveness of ovarian cancer C13* cells by a poly(ADP-ribose) polymerase inhibitor and the role of nuclear factor-κB.
Wang Z; Li Y; Lv S; Tian Y
J Int Med Res; 2013 Oct; 41(5):1577-85. PubMed ID: 24097829
[TBL] [Abstract][Full Text] [Related]
7. Interaction between inducible nitric oxide synthase and poly(ADP-ribose) polymerase in focal ischemic brain injury.
Park EM; Cho S; Frys K; Racchumi G; Zhou P; Anrather J; Iadecola C
Stroke; 2004 Dec; 35(12):2896-901. PubMed ID: 15514191
[TBL] [Abstract][Full Text] [Related]
8. Poly(ADP-ribose) polymerase inhibition suppresses inflammation and promotes recovery from adrenal injury in a rat model of acute necrotizing pancreatitis.
Yu J; Zuo T; Deng W; Shi Q; Ma P; Chen C; Zhao L; Zhao K; Wang W
BMC Gastroenterol; 2016 Jul; 16(1):81. PubMed ID: 27465581
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory mechanism of taurine against ischemic stroke is related to down-regulation of PARP and NF-κB.
Sun M; Zhao Y; Gu Y; Xu C
Amino Acids; 2012 May; 42(5):1735-47. PubMed ID: 21409386
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke.
Abdelkarim GE; Gertz K; Harms C; Katchanov J; Dirnagl U; Szabó C; Endres M
Int J Mol Med; 2001 Mar; 7(3):255-60. PubMed ID: 11179503
[TBL] [Abstract][Full Text] [Related]
11. Poly(ADP-ribose) polymerase-1 activity promotes NF-kappaB-driven transcription and microglial activation: implication for neurodegenerative disorders.
Chiarugi A; Moskowitz MA
J Neurochem; 2003 Apr; 85(2):306-17. PubMed ID: 12675907
[TBL] [Abstract][Full Text] [Related]
12. Calpain I inhibitor ameliorates the indices of disease severity in a murine model of cerulein-induced acute pancreatitis.
Virlos I; Mazzon E; Serraino I; Genovese T; Di Paola R; Thiemerman C; Siriwardena A; Cuzzocrea S
Intensive Care Med; 2004 Aug; 30(8):1645-51. PubMed ID: 15168010
[TBL] [Abstract][Full Text] [Related]
13. Critical role of the automodification of poly(ADP-ribose) polymerase-1 in nuclear factor-kappaB-dependent gene expression in primary cultured mouse glial cells.
Nakajima H; Nagaso H; Kakui N; Ishikawa M; Hiranuma T; Hoshiko S
J Biol Chem; 2004 Oct; 279(41):42774-86. PubMed ID: 15302869
[TBL] [Abstract][Full Text] [Related]
14. The chemical inhibitors of cellular death, PJ34 and Necrostatin-1, down-regulate IL-33 expression in liver.
Arshad MI; Piquet-Pellorce C; Filliol A; L'Helgoualc'h A; Lucas-Clerc C; Jouan-Lanhouet S; Dimanche-Boitrel MT; Samson M
J Mol Med (Berl); 2015 Aug; 93(8):867-78. PubMed ID: 25747661
[TBL] [Abstract][Full Text] [Related]
15. Improved Reperfusion and Vasculoprotection by the Poly(ADP-Ribose)Polymerase Inhibitor PJ34 After Stroke and Thrombolysis in Mice.
El Amki M; Lerouet D; Garraud M; Teng F; Beray-Berthat V; Coqueran B; Barsacq B; Abbou C; Palmier B; Marchand-Leroux C; Margaill I
Mol Neurobiol; 2018 Dec; 55(12):9156-9168. PubMed ID: 29651748
[TBL] [Abstract][Full Text] [Related]
16. Poly(ADP-ribose) polymerase 1 inhibition prevents interleukin-1β-induced inflammation in human osteoarthritic chondrocytes.
Sun Y; Zhou L; Lv D; Liu H; He T; Wang X
Acta Biochim Biophys Sin (Shanghai); 2015 Jun; 47(6):422-30. PubMed ID: 25926140
[TBL] [Abstract][Full Text] [Related]
17. Beneficial effects of PJ34 and INO-1001, two novel water-soluble poly(ADP-ribose) polymerase inhibitors, on the consequences of traumatic brain injury in rat.
Besson VC; Zsengellér Z; Plotkine M; Szabó C; Marchand-Verrecchia C
Brain Res; 2005 Apr; 1041(2):149-56. PubMed ID: 15829224
[TBL] [Abstract][Full Text] [Related]
18. Poly adenosine diphosphate-ribose polymerase inhibitor PJ34 abolishes systemic proinflammatory responses to thoracic aortic ischemia and reperfusion.
Black JH; Casey PJ; Albadawi H; Cambria RP; Watkins MT
J Am Coll Surg; 2006 Jul; 203(1):44-53. PubMed ID: 16798486
[TBL] [Abstract][Full Text] [Related]
19. PARP-1 inhibition attenuates neuronal loss, microglia activation and neurological deficits after traumatic brain injury.
Stoica BA; Loane DJ; Zhao Z; Kabadi SV; Hanscom M; Byrnes KR; Faden AI
J Neurotrauma; 2014 Apr; 31(8):758-72. PubMed ID: 24476502
[TBL] [Abstract][Full Text] [Related]
20. The therapeutic effects of PJ34 [N-(6-oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide.HCl], a selective inhibitor of poly(ADP-ribose) polymerase, in experimental allergic encephalomyelitis are associated with immunomodulation.
Scott GS; Kean RB; Mikheeva T; Fabis MJ; Mabley JG; Szabó C; Hooper DC
J Pharmacol Exp Ther; 2004 Sep; 310(3):1053-61. PubMed ID: 15159442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
